Critical Care Management of Diabetic Ketoacidosis Caused by Sodium-Glucose Co-Transporter 2 Inhibitor: A Case Report

Critical Care Management of Diabetic Ketoacidosis Caused by Sodium-Glucose Co-Transporter 2 Inhibitor: A Case Report

Bibliographic Details
Main Authors:	Elif Bombacı, Banu Çevik, Hakan Haydarlar, Kemal Tolga Saracoğlu, Recep Demirhan
Format:	Article
Language:	English
Published:	KARE Publishing 2020-10-01
Series:	Southern Clinics of Istanbul Eurasia
Subjects:	sodium-glucose co-transporter 2 inhibitors diabetic ketoacidoses intensive care
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-54872

Similar Items

Balancing Risks and Benefits: Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis
by: Jan P. Kleinjan, et al.
Published: (2024-03-01)

Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight
by: Awadhesh Kumar Singh
Published: (2015-01-01)

Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature
by: Alexis Diaz-Ramos, et al.
Published: (2019-09-01)

On‐label use of sodium–glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes
by: Takeshi Horii, et al.
Published: (2021-09-01)

Euglycemic diabetic ketoacidosis development in a patient with type 2 diabetes receiving a sodium-glucose cotransporter-2 inhibitor and a carbohydrate-restricted diet
by: Gwanpyo Koh, et al.
Published: (2023-09-01)

Sodium-glucose co-transporter 2 inhibitors – a review article
by: Marcin Makuch, et al.
Published: (2019-08-01)

Sodium-glucose co-transporter 2 inhibitors – a review article
by: Marcin Makuch, et al.
Published: (2019-08-01)

Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use
by: Stephen Melnick, et al.
Published: (2018-09-01)

Renal glucose handling in diabetes and sodium glucose cotransporter 2 inhibition
by: Resham Raj Poudel
Published: (2013-01-01)

Euglycemic diabetic ketoacidosis associated with sodium–glucose cotransporter-2 inhibitors after surgery: A case report and review of literature
by: Mei-An Pai, et al.
Published: (2023-01-01)

An atypical hyperosmolar hyperglycemic state and diabetic ketoacidosis induced by sodium–glucose cotransporter-2 inhibitors: A case report
by: Chen-Ti Wang, et al.
Published: (2020-08-01)

Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes
by: Koki Chiba, et al.
Published: (2021-02-01)

Sodium‑glucose co-transporter‑2 inhibitors in the treatment of diabetes with heart failure
by: Bo Liang, et al.
Published: (2022-05-01)

Re-emergence of a forgotten diabetes complication: Euglycemic diabetic ketoacidosis
by: Murat Dagdeviren, et al.
Published: (2024-01-01)

Severe intoxication caused by sodium-glucose cotransporter 2 inhibitor overdose: a case report
by: Miho Nakamura, et al.
Published: (2020-01-01)

The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy
by: Sha Su, et al.
Published: (2023-12-01)

Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients
by: Boyang Xiang, et al.
Published: (2021-04-01)

Sodium-glucose co-transporter-2 inhibitors in heart failure and chronic kidney disease: the role of empagliflozin
by: M. M. Batyushin
Published: (2021-04-01)

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
by: Jun Tang, et al.
Published: (2022-02-01)

Do sodium–glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real‐world study
by: Bin Zhao, et al.
Published: (2021-08-01)

Sodium–glucose cotransporter 2 inhibitors and anemia among diabetes patients in real clinical practice
by: Miho Murashima, et al.
Published: (2022-04-01)

Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions
by: Habib Yaribeygi, et al.
Published: (2023-01-01)

Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
by: Santos Cavaiola T, et al.
Published: (2018-04-01)

Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring
by: Keiichi Torimoto, et al.
Published: (2017-08-01)

The Predictive Value of Thoracic Computed Tomography on the Mortality of Critically Ill COVID-19 Patients
by: Elif Bombacı, et al.
Published: (2022-09-01)

Sodium–glucose cotransporter 2 inhibitor and sarcopenia in a lean elderly adult with type 2 diabetes: A case report
by: Megumi Yasuda, et al.
Published: (2020-05-01)

Glucose and Sodium Levels as Disease Outcome Predictors in Critically Ill Patients
by: Željka Dragila, et al.
Published: (2023-01-01)

Safety of sodium–glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations
by: Jaime A Davidson, et al.
Published: (2023-02-01)

Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus
by: Seung Eun Lee, et al.
Published: (2022-07-01)

Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey
by: Donato Cappetta, et al.
Published: (2021-12-01)

Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
by: Sarayut Lahnwong, et al.
Published: (2018-07-01)

SGLT2-Inhibitors and Euglycemia Diabetic Ketoacidosis: A Missed Diagnosis
by: Muhammad Nadeem Ahmed Khan, et al.
Published: (2023-12-01)

Case of hyperosmolar hyperglycemic state by a sodium-glucose cotransporter 2 inhibitor
by: In-Young Nho, et al.
Published: (2018-12-01)

Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
by: Nam Hoon Kim, et al.
Published: (2022-07-01)

Use of sodium glucose co‐transporter 2 inhibitors in acute heart failure: a practical guidance
by: João Pedro Ferreira, et al.
Published: (2022-12-01)

Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Trials
by: Yao Hao Teo, et al.
Published: (2021-03-01)

Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
by: Ji-Yeon Lee, et al.
Published: (2019-04-01)

Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases
by: Al-Anood Al-Shamasi, et al.
Published: (2021-11-01)

Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure
by: Muhammad Shariq Usman, et al.
Published: (2022-04-01)

Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
by: Akshyaya Pradhan, et al.
Published: (2019-01-01)